Business
OsteoSelect PLUS is designed to deliver differentiated handling properties and ensure patient safety through validated, terminal sterilization. ● 3Demin is a line of allograft bone products composed of 100% demineralized cortical bone.
Xtant Medical Holdings, Inc.: Revenue grew 14.2% to $134M from $117M. Net income turned positive at $4.973M from a $16.45M loss. Free cash flow turned positive at $10.16M from a $16.01M outflow. Operating margin expanded 1574 bps to 5.44%. Xtant Medical Holdings, Inc.'s annual comparison also shows the balance-sheet screen falls in the distress range and requires business-model context.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 14.2% to $134M from $117MOK
- Profitability — Net income turned positive at $4.973M from a $16.45M lossOK
- Cash flow — Free cash flow turned positive at $10.16M from a $16.01M outflowOK
- Margins — Operating margin expanded 1574 bps to 5.44%OK
- Accounting — Controls ineffective; weakness under remediationWatch
- Insiders — 0 purchases and 0 salesNote
Where the revenue comes from
Fiscal 2025, as Xtant Medical Holdings, Inc. reports it. History and quarterly detail are in the app.
- Product$115.2M
- Orthobiologics$72.9M
- Spinal Implant$42.3M
- License Revenue$18.7M
- License$18.7M
Leadership changes
From Xtant Medical Holdings, Inc.'s own filings, the day they're filed.
- Tyler Lipschultz · Directors · appointmenteff. 2025-08-01
- Robert McNamara · directors · departureeff. 2025-08-01
- Lori Mitchell-Keller · directors · departureeff. 2025-08-01
Latest filings
- 8-K · Company announcement2026-08-11
- 10-Q · Quarterly report2026-08-11
- 8-K · Company announcement2026-08-07
- DEF 14A · Annual proxy (pay & governance)2026-06-23
- 10-Q · Quarterly report2026-05-13
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Xtant Medical Holdings, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.